Excluding certain items, Pfizer's earnings were 58 cents, 1 cent above the average estimates of 15 analysts surveyed by Bloomberg. Sales fell 2 percent to $12.8 billion, above analyst estimates of $12.5 billion. Sales of Viagra, the erectile dysfunction pill, fell 11 percent to $427 million, including a 28 percent decline outside the U.S.
Pfizer's net income was $2.91 billion, or 45 cents a share, down from $14.1 billion, or $1.98 a share a year before, when Pfizer divested an animal health unit and received a legal settlement.
Share
